{
  "retracted": false,
  "timestamp": 1496275200000,
  "updates": [
    {
      "timestamp": 1585397758214,
      "identifier": {
        "doi": "10.2337/dc17-er06"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.2337/dc15-1643"
  },
  "publisher": "American Diabetes Association",
  "title": "Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241â€“1249"
}
